NERV - Minerva Neurosciences Inc
IEX Last Trade
2.73
-0.070 -2.564%
Share volume: 6,431
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$2.80
-0.07
-2.50%
Summary score
6%
Profitability
0%
Dept financing
10%
Liquidity
50%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-17.79%
Return on assets
-6.56%
Return on sales
0%
Return on invested capital
-24.22%
Total debt ratio
34.82%
Debt ratio change over timeo
4.2%
Current Ratio
12.2%
Quick Ratio
0%
Cash Position Ratio
6.95%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-33.77%
Return on assets
-0.6%
Return on sales
0%
Return on invested capital
-17.66%
Total debt ratio
40.78%
Debt ratio change over timeo
-1.67%
Current Ratio
5.96%
Quick Ratio
0%
Cash Position Ratio
4.47%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-13.98%
Return on assets
-12.4%
Return on sales
0%
Return on invested capital
-32.66%
Total debt ratio
11.04%
Debt ratio change over time
-0.91%
Current Ratio
6.49%
Quick Ratio
0%
Cash Position Ratio
6.05%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-261.16%
Return on assets
-228.61%
Return on sales
0%
Return on invested capital
-640.69%
Total debt ratio
419.73%
Debt ratio change over time
4.2%
Current Ratio
282.55%
Quick Ratio
0%
Cash Position Ratio
93.75%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | NERV | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -17.79% | -3.65% | 12.3% | 6.42% |
| Return on assets | -6.56% | 3.5% | 3.6% | 5.35% |
| Return on sales | 0% | 31.31% | 41.82% | 33.97% |
| Return on invested capital | -24.22% | 4.99% | 7.81% | 13.62% |
| Profitability | 0% | 44% | 81% | 83% |
| Total debt ratio | 34.82% | 101.15% | 75.51% | 29.75% |
| Debt ratio change over time | 4.2% | 224.03% | 6.03% | 1.46% |
| Dept financing | 9% | 50% | 19% | 8% |
| Current Ratio | 5.96% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 4.47% | 1.41% | 0.73% | 1.41% |
| Liquididy | 50% | 16% | 34% | 36% |
| Short-term ratios | NERV | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -33.77% | -16.17% | 18.05% | 7.63% |
| Return on assets | -0.6% | 2.71% | 3.58% | 5.03% |
| Return on sales | 0% | 29.9% | 36.22% | 35.56% |
| Return on invested capital | -17.66% | 6.54% | 5.97% | 19.39% |
| Profitability | 0% | 43% | 75% | 85% |
| Total debt ratio | 40.78% | 99.31% | 83.77% | 30.59% |
| Debt ratio change over time | -1.67% | 851.68% | 10.97% | 0.58% |
| Dept financing | 10% | 50% | 21% | 8% |
| Current Ratio | 5.96% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 4.47% | 1.41% | 0.73% | 1.41% |
| Liquididy | 50% | 33% | 25% | 47% |